"Extremities" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The farthest or outermost projections of the body, such as the HAND and FOOT.
| Descriptor ID |
D005121
|
| MeSH Number(s) |
A01.378
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Extremities".
Below are MeSH descriptors whose meaning is more specific than "Extremities".
This graph shows the total number of publications written about "Extremities" by people in this website by year, and whether "Extremities" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 7 | 11 |
| 2018 | 4 | 9 | 13 |
| 2019 | 2 | 4 | 6 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Extremities" by people in Profiles.
-
Acute limb ischemia among patients with COVID-19 infection. J Vasc Surg. 2022 01; 75(1):326-342.
-
Review of COVID-19, part 2: Musculoskeletal and neuroimaging manifestations including vascular involvement of the aorta and extremities. Clin Imaging. 2021 Nov; 79:300-313.
-
Novel fusion sarcomas including targetable NTRK and ALK. Ann Diagn Pathol. 2021 Oct; 54:151800.
-
CMAJ. 2021 07 05; 193(26):E1021-E1026.
-
Group A Streptococcus necrotising myositis of the limbs secondary to cavitating pneumonia. BMJ Case Rep. 2021 Apr 07; 14(4).
-
How Does SARS-CoV-2 Infection Affect Survival of Emergency Cardiovascular Patients? A Cohort Study From a German Insurance Claims Database. Eur J Vasc Endovasc Surg. 2021 07; 62(1):119-125.
-
Reply For: "Re: Endotheliitis in COVID-19-Positive Patients After Extremity Amputation for Acute Thrombotic Events". Ann Vasc Surg. 2021 05; 73:143.
-
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study. Am Heart J. 2021 05; 235:12-23.
-
Severely injured patients do not disappear in a pandemic: Incidence and characteristics of severe injuries during COVID-19 lockdown in Finland. Acta Orthop. 2021 06; 92(3):249-253.
-
Incidence, Predictors, and Outcomes of Thrombotic Events in Hospitalized Patients With Viral Pneumonia. Am J Cardiol. 2021 03 15; 143:164-165.